We are live on ! Find out more
Walleye Capital

Walleye Capital Portfolio holdings

AUM $24B
1-Year Est. Return 37.67%
This Fund
S&P 500
This Quarter Est. Return
+0.19%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
AUM
$56.1B
AUM Growth
-$74.1M
Cap. Flow
-$2.18B
Cap. Flow %
-3.9%
Top 10 Hldgs %
32.94%
Holding
6,229
New
863
Increased
2,149
Reduced
1,963
Closed
717

Sector Composition

Rank Sector Weight
1 Technology 3.4%
2 Consumer Discretionary 2.47%
3 Healthcare 2.01%
4 Industrials 1.61%
5 Financials 1.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LII icon
2226
Lennox International
LII
$15B
$1.65M ﹤0.01%
3,081
-9,482
-75% -$4.67M
EXAS
2227
PUT
DELISTED
Exact Sciences
EXAS
$1.65M ﹤0.01%
39,000
+22,100
+131% +$1.22M
TGTX icon
2228
PUT
TG Therapeutics
TGTX
$8.19B
$1.64M ﹤0.01%
92,300
+30,700
+50% +$490K
GTLB icon
2229
CALL
GitLab
GTLB
$5.75B
$1.64M ﹤0.01%
33,000
-24,800
-43% -$1.29M
LZB icon
2230
La-Z-Boy
LZB
$1.64B
$1.64M ﹤0.01%
44,001
+16,765
+62% +$592K
BMA icon
2231
PUT
Banco Macro
BMA
$5.81B
$1.64M ﹤0.01%
28,600
+15,900
+125% +$912K
IREN icon
2232
Iris Energy
IREN
$10.5B
$1.64M ﹤0.01%
145,000
+63,196
+77% +$474K
RYAAY icon
2233
Ryanair
RYAAY
$30B
$1.64M ﹤0.01%
+35,140
New +$1.83M
SM icon
2234
SM Energy
SM
$7.6B
$1.64M ﹤0.01%
37,843
+37,233
+6,104% +$1.83M
CERE
2235
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$1.64M ﹤0.01%
40,000
EMBC icon
2236
Embecta
EMBC
$218M
$1.63M ﹤0.01%
130,685
+96,633
+284% +$1.17M
ALGN icon
2237
Align Technology
ALGN
$12.9B
$1.63M ﹤0.01%
6,758
-2,200
-25% -$612K
VNOM icon
2238
PUT
Viper Energy
VNOM
$8.43B
$1.63M ﹤0.01%
43,400
-75,700
-64% -$2.88M
SCPH
2239
DELISTED
scPharmaceuticals
SCPH
$1.63M ﹤0.01%
374,407
-181,779
-33% -$799K
LH icon
2240
CALL
Labcorp
LH
$25.2B
$1.63M ﹤0.01%
8,000
-100
-1% -$20.3K
RHI icon
2241
CALL
Robert Half
RHI
$4.11B
$1.63M ﹤0.01%
25,400
+10,600
+72% +$727K
VSAT icon
2242
PUT
Viasat
VSAT
$9.67B
$1.62M ﹤0.01%
127,900
+30,800
+32% +$491K
TREX icon
2243
Trex
TREX
$4.4B
$1.62M ﹤0.01%
21,873
+12,994
+146% +$1.14M
CGEM icon
2244
Cullinan Oncology
CGEM
$1.06B
$1.62M ﹤0.01%
+92,869
New +$1.98M
RRC icon
2245
CALL
Range Resources
RRC
$9.33B
$1.62M ﹤0.01%
48,300
+22,300
+86% +$802K
PBF icon
2246
CALL
PBF Energy
PBF
$7.49B
$1.62M ﹤0.01%
35,100
+9,000
+34% +$461K
ARES icon
2247
CALL
Ares Management
ARES
$28.1B
$1.61M ﹤0.01%
12,100
+11,600
+2,320% +$1.58M
KEX icon
2248
Kirby Corp
KEX
$7.01B
$1.61M ﹤0.01%
13,455
+81
+0.6% +$9.05K
EXE
2249
CALL
Expand Energy Corp
EXE
$21.4B
$1.61M ﹤0.01%
19,600
+12,900
+193% +$1.14M
AVT icon
2250
CALL
Avnet
AVT
$6.86B
$1.61M ﹤0.01%
31,200
+22,200
+247% +$1.14M

Similar funds

Walleye Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Walleye Capital held 6,229 positions worth $56.1B, down 0.13% from $56.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Walleye Capital withdrew a net $2.18B in Q2 2024, closing 717 positions and reducing 1,963 holdings. Its most notable exit was TXNM Energy Inc, an estimated $33.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 2.9% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Walleye Capital opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $39.1M.

  • Walleye Capital's largest Q2 2024 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 365,000 shares worth $39.1M.
  • Walleye Capital added most to Ansys in Q2 2024, an estimated $88.3M increase.
  • Walleye Capital's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $201M.
  • Walleye Capital fully exited TXNM Energy Inc in Q2 2024, selling an estimated $33.6M.
  • Walleye Capital's ten largest holdings make up 33% of its $56.1B portfolio in Q2 2024.
  • Walleye Capital opened 863 new positions and closed 717 in Q2 2024.
  • Walleye Capital's portfolio value fell 0.13% quarter-over-quarter to $56.1B.

Based on Walleye Capital's 13F filing for Q2 2024, filed 14 Aug 2024.